1. Background {#sec103743}
=============

The prevalence of noncommunicable diseases is rising rapidly in many countries due to factors such as increased life expectancy, increased exposure to risk factors and changes in lifestyle ([@A28238R1]). In 1990, in terms of the global burden of diseases, noncommunicable diseases were placed among the first fifteen ranks ([@A28238R2]). As the statistical estimations have revealed, these conditions will rise among the first six ranks by 2020 ([@A28238R1], [@A28238R2]).

Atherosclerosis, which is among the most important global health concerns, is a slow progressive disease. This condition occurs due to the thickening of coronary arteries. Annually, more than 900 thousand deaths occur in the US due to cardiovascular diseases, and three-quarters of these diseases are associated with Coronary Artery Disease (CAD) ([@A28238R3]). In Iran, cardiovascular diseases, especially CAD, are the first and most common cause of mortality in men and women ([@A28238R3], [@A28238R4]).

The treatment costs of cardiovascular diseases imposed on individuals and society are substantial. In the coming years, these conditions will affect a vast majority of working population in developing countries; therefore, cardiovascular diseases are expected to be a heavy financial burden on developing countries ([@A28238R5]).

Current knowledge indicates that the prevention of cardiovascular diseases, based on the determining factors, requires a set of interventions. In cases such as smoking, these interventions must anticipate the medical and social needs of cardiac patients in relation to their family and community ([@A28238R3]).

In the past, the only way to prevent early morbidity and mortality, associated with cardiovascular diseases, was the third level of prevention. However, today, through recognizing the contributing risk factors such as urbanization, poor diet, economic status, air pollution, physical inactivity, mental stress, and smoking, we can promote public health by focusing on primary prevention, lifestyle changes, and elimination of risk factors for cardiac diseases ([@A28238R6]).

2. Objectives {#sec103744}
=============

Among previously performed studies in Iran and other countries, the present research is admittedly the first study on CADs, which aimed to evaluate demographic and socioeconomic factors in three treatment groups: Coronary Artery Bypass Grafting (CABG), Percutaneous Coronary Intervention (PCI) and drug therapy. By identifying and comparing the underlying factors, we can gather useful information for future planning and policy making to reduce and eradicate the contributing factors.

3. Patients and Methods {#sec103746}
=======================

This cross-sectional study was conducted on 760 patients with CAD referred to cardiovascular referral health centers in Mashhad, the north east of Iran, including general, governmental, educational, clinical and para-clinical Hospitals named Qaem with 780 beds, Imam Reza with 918 beds, Dr. Shariati with 300 beds and also Javad-al-Aeme, the specialized and referral private heart center with 460 beds. These centers provide health care for most patients with cardiovascular diseases in Mashhad; therefore, they are good representatives of the population with cardiovascular diseases.

Samples were collected using purposive sampling. All cases with CAD referred to cardiovascular health centers in Mashhad from January to March 2014 were considered to be as a study sample and were followed. The cases were categorized based on the treatment diagnosis made by cardiologists and cardiac surgeons into three treatment groups: CABG, PCI and drug therapy.

The inclusion criteria were diagnosis of CAD and age range of 35-70 years. The exclusion criteria were as follows: 1) ejection fraction \< 35% on echocardiography; 2) prior history of other conditions such as renal diseases, peripheral arterial occlusive disease, mobility problems, chronic obstructive pulmonary disease, and mental disorders; and 3) previous bypass surgery. The sample size of 250 patients in each group at baseline with the formula of [Equation 1](#EQ2900){ref-type="disp-formula"} was considered.
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At the march 2014, we got the study sample consisted of 760 individuals, including 251 cases in the drug therapy group, 236 patients in the PCI group and 273 patients in the CABG group. Economic, social, demographic and clinical data including age, sex, Body Mass Index (BMI), prior myocardial infarction, and previous coronary angiography were extracted from patients' medical records using a checklist. This checklist was created by a joint panel of cardiologists, cardiac surgeons and community medicine specialists for the accuracy and precision of the equipment. A nurse practitioner with an advanced coursework in cardiac diseases completed the information of the checklist.

The patients were enrolled in the study after obtaining informed consents. This study was approved by the ethics committee of Mashhad University of Medical Sciences (approval code: 920375).

3.1. Statistical Analysis {#sec103745}
-------------------------

Data were analyzed by SPSS version 11.5. (SPSS Inc., Chicago, IL, USA) Characteristics of the three groups were expressed using descriptive statistics, central tendency and dispersion that were presented as mean, median, variance, and standard deviation. The chi-square test was used to compare qualitative variables. Assessment of the data normality was done by SPSS. ANOVA test was used to compare normal quantitative variables between the groups and to determine whether there are any significant differences among the means of three independent groups. For the data that meet the assumption of homogeneity of variances, Tukey's Honestly Significant Difference (HSD) post-hoc tests were used and for the data did not meet the assumption of homogeneity of variances, the Dunnett's C post-hoc tests were considered. The Kruskal-Wallis test was used for continuous or ordinal dependent variables among the groups. In all calculations, P value less than 0.05 was considered statistically significant.

4. Results {#sec103747}
==========

Socioeconomic and demographic characteristics of the study population are presented in [Table 1](#tbl26699){ref-type="table"}. From a total of 760 patients, 236 (31%), 273 (36%), and 251 (33%) patients were treated by PCI, CABG and drug therapy, respectively. The mean age of patients was 11.5 ± 58.3 years, which was not significantly different among the three groups (P = 0.09).

###### Baseline Characteristics of the Study Population in the Treatment Groups ^[a](#fn25599){ref-type="table-fn"},[b](#fn25600){ref-type="table-fn"}^

  Characteristics                                                                         Treatment Group   Total (N = 760)   P Value                             
  --------------------------------------------------------------------------------------- ----------------- ----------------- ----------------- ----------------- ------------------------------------------------------------------------------
  **Age, y**                                                                              11.41 (57.59)     59.55 (10.34)     57.65 (12.60)     58.3 (11.5)       0.09 ^[c](#fn25601){ref-type="table-fn"},[d](#fn25602){ref-type="table-fn"}^
  **Gender**                                                                                                                                                      \< 0.001 ^[e](#fn25603){ref-type="table-fn"}^
  Male                                                                                    130 (55.1)        186 (68.1)        131 (52.2)        447 (58.8)        
  Female                                                                                  106 (44.9)        87 (31.9)         120 (47.8)        313 (41.3)        
  **Residence status**                                                                                                                                            \< 0.001 ^[e](#fn25603){ref-type="table-fn"}^
  Urban                                                                                   173 (73.3)        241 (88.3)        182 (72.5)        596 (78.4)        
  Rural                                                                                   63 (26.7)         32 (11.7)         69 (27.5)         164 (21.6)        
  **Marital status**                                                                                                                                              0.06 ^[e](#fn25603){ref-type="table-fn"}^
  Married                                                                                 211 (89.4)        208 (76.2)        220 (87.6)        639 (84.1)        
  Single                                                                                  2 (0.9)           32 (11.7)         9 (3.6)           43 (5.6)          
  Widowed or divorced                                                                     23 (9.7)          33 (12.1)         22 (8.8)          78 (10.3)         
  **Educational level**                                                                                                                                           0.006 ^[f](#fn25604){ref-type="table-fn"}^
  Lower than high school diploma                                                          173 (73.3)        175 (64.1)        190 (75.7)        538 (70.8)        
  High school diploma and higher                                                          63 (26.7)         98 (35.9)         61 (24.3)         222 (29.2)        
  **Occupational status**                                                                                                                                         \< 0.001 ^[e](#fn25603){ref-type="table-fn"}^
  Unemployed                                                                              54 (22.9)         103 (37.7)        60 (23.9)         217 (28.6)        
  Employee                                                                                88 (37.3)         87 (31.9)         80 (31.9)         255 (33.5)        
  Housewife                                                                               94 (39.8)         83 (30.4)         111 (44.2)        288 (37.9)        
  **Insurance coverage**                                                                                                                                          0.008 ^[e](#fn25603){ref-type="table-fn"}^
  Yes                                                                                     185 (78.4)        250 (91.6)        225 (89.6)        660 (86.9)        
  No                                                                                      15 (6.4)          3 (1.1)           17 (6.8)          35 (4.6)          
  **Supplemental insurance**                                                              36 (7.3)          20 (7.3)          9 (3.6)           65 (8.5)          
  **BMI, kg/m** ^**2**^                                                                   25.73 (2.92)      26.18 (3.45)      26.30 (3.85)      26.07 (3.43)      0.181 ^[g](#fn25605){ref-type="table-fn"}^
  **Monthly income of patients, USD** ^**[h](#fn25606){ref-type="table-fn"}**^            238.15 (135.67)   277.67 (157.4)    266.39 (169.83)   255.56 (154.81)   0.561 ^[i](#fn25607){ref-type="table-fn"}^
  **Smoking**                                                                             39 (16.6)         94 (34.5)         78 (31.1)         211 (27.7)        \< 0.001 ^[e](#fn25603){ref-type="table-fn"}^
  **Alcohol**                                                                             2 (0.8)           6 (2.2)           12 (4.8)          20 (2.6)          0.02 ^[e](#fn25603){ref-type="table-fn"}^
  **Narcotic and drug**                                                                   17 (7.2)          28 (10.2)         37 (14.7)         82 (10.8)         0.03 ^[e](#fn25603){ref-type="table-fn"}^
  **Diabetes**                                                                            63 (26.7)         169 (61.9)        153 (60.7)        385 (50.7)        0.05 ^[e](#fn25603){ref-type="table-fn"}^
  **Hypertension**                                                                        130 (55.1)        127 (46.5)        138 (55)          395 (52)          0.21 ^[e](#fn25603){ref-type="table-fn"}^
  **The number of affected coronary arteries** ^**[j](#fn25608){ref-type="table-fn"}**^                                                                           \< 0.001 ^[f](#fn25604){ref-type="table-fn"}^
  One                                                                                     15 (23.9)         4 (4.3)           81 (35.8)         100 (26.1)        
  Two                                                                                     22 (34.9)         13 (13.8)         84 (37.2)         119 (31.1)        
  Three                                                                                   26 (41.2)         77 (81.9)         61 (27)           164 (42.8)        

^a^ Abbreviations: BMI, body mass index; PCI, percutaneous coronary intervention; and CABG, coronary artery bypass graft.

^b^ The numbers in the table are expressed as mean (SD) or No. (%), based on the type of variable.

^c^ Analysis by ANOVA.

^d^ Post hoc test between groups P \> 0.005.

^e^ Analysis by chi-square test.

^f^ Analysis by the Kruskal Wallis test.

^g^ Post hoc test between groups P \> 0.005.

^h^ Iranian rial currency exchange rate against the dollar considered by an average of 26500 rial equal one US dollar.

^i^ Post hoc test between groups P \> 0.005.

^j^ Among 760 patients, 383 cases of coronary involvement were determined.

Regarding the gender distribution, 59% of the subjects were male and 41% were female. In terms of gender distribution in the three groups, the number of women was higher in the drug therapy and PCI groups compared to the CABG group (47.8% and 44.9% vs. 31.9%); the difference was statistically significant (P \< 0.001).

In total, 77.8% of the studied patients were urban residents and 22.2% were residing in rural areas. In terms of rural population distribution in the three groups, the ratio of rural subjects to urban patients in the drug therapy and PCI groups was twice as high as the CABG group (27.5% and 26.7% vs. 11.7%); also, the difference was statistically significant (P \< 0.001).

In terms of marital status, although the CABG group was twice higher than two other treatment groups in single patients, the difference was statistically insignificant (P = 0.06). Distribution of patients' educational level in the drug therapy and PCI groups was nearly identical. However, the proportion of the patients with a higher educational level in the CABG group was about 1.5 times higher than other groups; this difference was statistically significant (P = 0.006). In terms of occupational status, proportion of housewives in the drug therapy and PCI groups was significantly higher than the CABG group (P = 0.05).

In terms of health insurance coverage, lack of the insurance coverage in the drug therapy and PCI groups was twice as common as the CABG group. Also, supplemental insurance coverage in the CABG and PCI groups was more than twice as common as the drug therapy group; these differences were statistically significant (P = 0.008). The mean BMI in three treatment groups indicated overweight, although no significant difference was observed among the three groups (P = 0.18). Moreover, no significant difference was observe in a monthly income among the three groups (P = 0.56).

In total, 27.2% of the patients smoked cigarettes. Smoking in the drug therapy and CABG groups was twice as common as the PCI group and the difference was statistically significant. Overall, 2.4% of patients consumed alcohol and 10.6% used drugs. Alcohol and drug abuse in the drug therapy group was about twice as common as the PCI and CABG groups; the difference was also statistically significant (P = 0.02 and P = 0.03, respectively).

Moreover, 51% of the patients had a prior history of diabetes. Diabetes in the drug therapy and CABG groups was significantly more common than the PCI group (twice as common) (P = 0.05). Also, 52% of patients reported no prior history of hypertension. However, hypertension in the three treatment groups was not significantly different (P = 0.21).

As can be seen in [Table 1](#tbl26699){ref-type="table"}, among 760 patients, 383 cases of coronary involvement were determined by angiography. One-vessel CAD in the drug therapy group was more common than the other two groups. On the other hand, three-vessel CAD was more prevalent in the CABG group compared to other treatment groups. The number of affected vessels was significantly different between the three groups (P \< 0.001).

The number of involved vessels is presented in [Table 2](#tbl26700){ref-type="table"}, based on patients' clinical and demographic characteristics. The prevalence of one-vessel CAD was similar in female and male patients. However, two- and three-vessel CAD in male patients was more common than female patients; the difference was statistically significant (P = 0.02). Distribution of the number of affected coronary arteries in rural patients was significantly different from that reported in urban patients. In fact, three-vessel CAD was less common than one- or two-vessel CAD in rural patients (P = 0.005). However, no significant relationship was observed between the number of affected coronary arteries and BMI or economical status (P = 0.17 and P = 0.37, respectively). Although the prevalence of three-vessel CAD was higher in smokers, the difference was not statistically significant (P = 0.16). Also, alcohol abuse was not significantly different between patients with different types of CAD (P = 0.07). Drug abuse in patients with one-vessel CAD was significantly more prevalent than patients with two- or three-vessel CAD (P = 0.03). As presented in [Table 2](#tbl26700){ref-type="table"}, increased number of affected vessels was correlated with the incidence of diabetes and hypertension (P = 0.001 and P \< 0.001, respectively).

###### Distribution of Factors Associated With the Incidence of Coronary Artery Disease and Disease Severity in Study Patients ^[a](#fn25609){ref-type="table-fn"},[b](#fn25610){ref-type="table-fn"}^

  Characteristic                                                                 1VD (N = 100)   2VD (N = 119)   3VD (N = 164)     P Value ^[c](#fn25611){ref-type="table-fn"}^
  ------------------------------------------------------------------------------ --------------- --------------- ----------------- ------------------------------------------------------------------------------
  **Gender**                                                                                                                       
  Female                                                                         49 (49)         47 (39.4)       50 (30.5)         0.02
  Male                                                                           51 (51)         72 (60.6)       114 (69.5)        
  **Residence status**                                                                                                             
  Urban                                                                          79 (79)         88 (74)         147 (89.6)        0.005
  Rural                                                                          21 (21)         31 (26)         17 (10.4)         
  **Educational level**                                                                                                            
  Lower than high school diploma                                                 74 (74)         89 (74.8)       100 (61)          0.005
  High school diploma and higher                                                 26 (26)         30 (25.2)       64 (39)           
  **BMI, kg/m** ^**2**^                                                          26.3 (3.7)      27.3 (4.2)      26.3 (3.1)        0.37 ^[d](#fn25612){ref-type="table-fn"},[e](#fn25613){ref-type="table-fn"}^
  **Monthly income of patients, USD** ^**[f](#fn25614){ref-type="table-fn"}**^   344 (183.77)    228.11 (102)    298.25 (166.88)   0.71 ^[d](#fn25612){ref-type="table-fn"},[g](#fn25615){ref-type="table-fn"}^
  **Smoking**                                                                    25 (25)         30 (25.2)       59 (35.6)         0.16
  **Alcohol**                                                                    7 (7)           15 (12.6)       5 (3)             0.07
  **Narcotic and drug**                                                          21 (21)         11 (9.3)        20 (12.1)         0.03
  **Diabetes**                                                                   18 (18)         27 (22.7)       97 (59.1)         \< 0.001
  **Hypertension**                                                               7 (7)           32 (26.9)       33 (20.1)         0.001

^a^ Abbreviations: BMI, body mass index; VD, vessel disease.

^b^ The numbers in the table are expressed as No. (%) or Mean (SD) based on the type of variable.

^c^ Analysis by chi-square.

^d^ Analysis by ANOVA.

^e^ Post hoc test between groups P \> 0.005.

^f^ Iranian rial currency exchange rate against the dollar considered by an average of 26500 rial equal one US dollar.

^g^ Post hoc test between groups P \> 0.005.

5. Discussion {#sec103748}
=============

Risk factors for ischemic heart disease can accelerate the chronic inflammatory process, which leads to atherosclerotic plaque ([@A28238R7]). The obtained results showed that the proportion of male patients was higher in the CABG group compared to other treatment groups. Also, the subjects in the CABG group were older than those in other groups. These findings were in agreement with the results of a review study on ten trials, comparing CABG and PCI in patients with multi-vessel CAD ([@A28238R8]).

In this study, the proportion of rural patients in the CABG group was far less than that reported in the PCI and drug therapy groups. Many factors such as the severity and type of coronary artery occlusion, urgency of treatment, physicians' medical advice, and the patient\'s decision contribute to the selection of a treatment method. Moreover, the decision for the preliminary treatment is influenced by disease severity, patient's general condition, and age. In addition, preference for a treatment method is dependent on hospital facilities and the patient's economic status ([@A28238R9]). In this study, access to hospital facilities and patients' economic status affected their choice of treatment modality.

The results of this study revealed that subjects in the CABG and PCI groups were more educated than the drug therapy group (higher than high school diploma). Also, the proportion of patients with lower educational level (less than diploma) was the highest in the drug therapy group. This difference may be due to the correlation among educational level, income level and social class. In fact, patients with a high income have more access to CABG and PCI methods, which are costly modes of treatment; this could be one of the criteria for selecting the treatment method. Smith and colleagues also showed a significant relationship between education and therapeutic techniques ([@A28238R10]).

Insurance coverage in the CABG and PCI groups was twice as common as the drug therapy group. Given the substantial costs of CABG and PCI treatments compared to drug therapy, it seems that supplemental insurance coverage plays a contributing role in choosing the treatment method. Federman and colleagues also evaluated the effect of supplemental insurance on treatment methods in patients with CAD ([@A28238R11]). The results revealed a significant correlation between insurance coverage and effective treatment methods ([@A28238R11]).

In this study, diabetes mellitus in the CABG group was significantly more prevalent than that reported in drug therapy group. On the other hand, the number of affected coronary arteries was significantly higher in the CABG group compared to other treatment groups. If we consider the number of affected coronary arteries as an indication of the severity of CAD, diabetes mellitus is significantly associated with the severity of CAD. The same findings were reported regarding cigarette smoking.

Several epidemiological studies have shown that diabetes and smoking are major risk factors for CAD ([@A28238R4], [@A28238R12], [@A28238R13]). Some previous studies have noted that risk of CAD in diabetic patients is three to four times higher than nondiabetic patients ([@A28238R14], [@A28238R15]). Kanitz and colleagues in a study, which aimed to determine the major risk factor for CAD, introduced cigarette smoking as the most important risk factor for myocardial infarction in patients younger than 40 years ([@A28238R16]). The results showed that the number of affected coronary arteries (i.e. disease severity) in male patients was higher than female patients. Moreover, several studies have noted that estrogen acts as a protective factor against CAD. In fact, CAD might develop in one-third of men compared to one-fifth of women until the age of 60 ([@A28238R17], [@A28238R18]).

In this study, the number of affected coronary arteries (three coronary arteries) in urban patients was higher than that reported in rural patients. It seems that patterns of urban life and the risk factors affect the severity of CAD. Epidemiological studies have shown that in developing countries, exposure to risk factors for CAD has increased. Globalization, urbanization and behavioral changes are considered as significant contributing factors ([@A28238R19]). Moreover, some studies have shown that CAD is two to three times more prevalent in urban population compared to rural population, perhaps due to immobility and urban lifestyle ([@A28238R20]).

The results of this study showed that the use of alcohol and drugs was more common in patients with more than one affected coronary vessel. Some studies have introduced alcohol abuse as a risk factor for hypertension and cardiovascular diseases ([@A28238R21]). Moreover, Darabian and Abbasi investigated the risk factors for ischemic heart disease. Drug addiction, similar to other cardiovascular risk factors, was noted as an independent risk factor for CAD ([@A28238R22]). However, in patients with a higher number of affected vessels, alcohol and drugs may be used to relieve the pain.

The strengths of our study include a large sample size and a comprehensive estimation of the demographic and socioeconomic factors of CAD patients in three treatment groups of CABG, PCI and drug therapy. Also, the results of this study, the first of its kind in Iran, describe a good coverage from multicenteral health cares in Mashhad City, Iran, with the majority of patients having cardiovascular disease. A limitation of our study is that insufficient data from patients' medical records led to have missing data in some cases. This was a missing by natural design; so, we used univariate t-test for generalized estimating equations with missing data.

In conclusion, this study showed that by increasing involvement of coronary arteries, the prevalence of diabetes and hypertension increases in patients. Several studies have introduced diabetes and high-blood pressure as risk factors for CAD, independent of other risk factors. In fact, by a 20-mmHg increase in systolic blood pressure and a 10-mmHg rise in diastolic blood pressure, the risk of CAD-related mortality is doubled ([@A28238R23]). Based on studies on diabetic patients, reduced low-density lipoprotein and increased high-density lipoprotein are among the risk factors for the atherosclerotic process ([@A28238R17]).

Based on the current results, although the treatment choice is influenced by disease severity, type of occlusion, urgency of treatment, clinical diagnosis, and patient's preference, hospital facilities and patient's economic status are also highly influential. In other words, treatment method is selected based on disease severity, clinical diagnosis, patient's preference and socioeconomic constraints and requirements. It can be also concluded that risk factors for CAD such as gender, lifestyle, smoking, alcohol abuse, diabetes and hypertension are not only correlated with the incidence of CAD, but also significantly associated with the severity of this condition.
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